History
February 2022
In February 2022, it was approved as an experimental base for modern medical and pharmaceutical industry development in Anhui Province.
2021
At the end of 2021, the chemiluminescence and microfluidics projects will be included in the "14th Five-Year Development Plan of Hefei City";
December 2021
In December 2021, the preparation for Huibang Biological Postdoctoral Workstation will be launched;
December 2021
In December 2021, the fourth batch of new research and development institutions in Anhui Province;
2020
The second prize of the Yangtze River Delta Biomedical Competition in 2020;
2019
2019 Anhui Province Biomedical Strategic Emerging Industry Base;
April 2019
The company was successfully listed in the Anhui Equity Custodian Trading Center, listing code: 630215, marking that the company has officially entered the listing incubation period, laying a solid foundation for the company to achieve its strategic goals;
March 2019
Obtained the product registration certificate of "Abortion Prevention and Preterm Birth Test Kit", and sold and promoted it in the national market. The contract volume of a single product was nearly 70 million yuan;